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OBJECTIVES: Research has shown that a direct suggestion for a patient to schedule
an appointment encourages patients to attend their appointments more regularly,
which has a direct correlation with improved outcomes. The study’s objectives
were to determine the relationship between telephone/mail intervention and clin-
ical pharmacist appointment adherence rates; and whether patients who saw a
clinical pharmacist 3 more times had significantly different HbA1c levels com-
pared to those who did not see a clinical pharmacist.METHODS: This was a retro-
spective review of a central Texas community health center outpatient electronic
medical record from 9/1/2009-1/13/2012. Included patients were adult (18-80 years)
type 2 diabetes mellitus patients with HbA1c9. Patients with working telephone
numbers were contacted. Those who could not be reached via telephone (e.g., no
working number or no answer) or who did not schedule an appointment after the
telephone intervention were contacted by mail. Contact method type (telephone,
mail, telephone and mail), number of clinical pharmacist visits, HbA1c levels (6
months prior and one year post initial appointment) and demographics were col-
lected. Appointment adherence was calculated as kept visits/total number of pa-
tients in each contact method. RESULTS: Patients (N132) were 53.312.4 years,
52.3% female, and 72.7% Hispanic. Patients’ appointment adherence rates (raw
numbers;rate) for telephone (52/67;77.6%) were higher than mail (14/43;32.6%) and
telephone and mail (4/22;18.2%) contact methods. Although not significant
(p0.1067), the change in HbA1c from baseline to follow-up (third HbA1c) de-
creased more with patients (N40) who visited the pharmacist3 times (-2.42.2)
compared to patients (N24) who did not visit their pharmacists (-1.52.3).
CONCLUSIONS: Healthcare practitioners should consider calling or mailing type 2
diabetes patients with uncontrolled diabetes to increase appointment adherence
andhelp patients get better control of their diabetes. Patientswho saw their clinical
pharmacists 3 times had a 2.4% drop in HbA1c.
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OBJECTIVES: The objective was to analyze the disease management of diabetes in
Shanghai Minhang district and to provide evidence for improving management
practices in the future. METHODS: The program screened for diabetes in 12 com-
munity health centers with totally 943 thousands population, built up an informa-
tion system of Electronic Health Record (EHR), and conducted various forms of
follow-up visits and disease management with different time spans according to
patients’ diabetes situation. RESULTS: There were 43,709 diabetes patients man-
aged during the study period from October 2008 to September 2009, including
Type1 diabetes (T1DM), Type2 diabetes (T2DM), impaired glucose tolerance (IGT),
and impaired fasting glucose (IFG) patients. Based on the last follow-up visit during
the study period, 82.91% of managed diabetes patients monitored blood sugar reg-
ularly, while only 1.50% did not monitor at all. The percentage of patients who
monitored diet completely according to doctor’s suggestion was 81.37%. 92.91% of
type 1 diabetes patients were taking medication and the percentage of patients
using insulin was 36.32%. The percentage of type 2 diabetes patients using insulin
is only 12.37%. Based on the last follow-up visit during the study period, the average
fasting plasma glucose (FPG) was 7.051.91mmol/L and the average postprandial
plasma glucose (PPG) was 8.643.29mmol/L. The percentage of the patients whose
blood sugar level was considered to be ideal, fair, and poor was 36.12%, 32.53% and
31.34% respectively. As with HbA1C level, the number was 67.27%, 20.08% and
12.65%, although the percentage of HbA1C recorded in the system was relatively
low. CONCLUSIONS: The management of diabetes in Shanghai Minghang district
performedwell in terms of blood sugarmonitoring and diet monitoring. There was
need, however, to improve exercise involvement. The blood sugar control was not
ideal from clinical perspective, suggesting needs to improve diabetesmanagement
for blood sugar control.
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OBJECTIVES:Diet and exercise are key elements alongwith pharmacological treat-
ment to attain adequate glycemic control in diabetic persons. The aim of this study
is to identify the socio-demographic factors and attitudes associated with the fol-
lowing of diet and exercise plans in the treatment of diabetic patients at the Mex-
ican Institute of Social Security (IMSS). METHODS: Data from the institutional
health survey, encoprevenimss 2010, was used to test the statistical relationship
between socio-demographic variables and adherence to diet and exercise plans in
the treatment of diabetic patients aged 20 years and older. Two binary logistic
regression models were constructed to identify personal attitudes and socio-de-
mographic variables associated with the decision of the patient whether to follow
the recommendations. RESULTS: 31% of the patients reported fully adhering to the
prescribed diet, 25% adhered partially and 8% did not adhere to it; furthermore 27%
of the patients reported fully complying with the exercise recommendations, 16%
complied partially and 18% did not comply. At a level of significance of 5%, no
statistically significant relationship between following diet and exercise plans and
gender was found, with p-value  0.072 and 0.424 respectively. In contrast, a sta-
tistically significant relationship with age groups was obtained, p-value  0.000.
The results from the logistic regression models show that the main predictors for
whether patients would follow recommendations for diet and exercise were per-
sonal attitudes. Lack of interest or motivation regarding the importance of these
recommendations increases the probability of poor adherence. With improved
education, the probability of greater adherence to these recommendations in-
creases, while patients who work are less likely to exercise or follow the diet plan.
CONCLUSIONS: Health programs and activities aiming to motivate patients to fol-
low diet and exercise plans should be designed with special emphasis on diabetic
patients who work.
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OBJECTIVES: To improve the health outcomes and reduce costs of employees with
diabetes, many employers are initiating diabetes disease management interven-
tions. Given the variety of programs and lack of definitive guidelines reported in the
literature, identifying the most appropriate strategy can be challenging. To con-
tribute to employers’ understanding of diabetes disease management programs
and determine which are most likely to be successful, this review sought to assess
the interventions reported in the literature. METHODS: A systematic review of
PubMed, Embase and Cochrane was performed. Publications reporting the out-
comes of diabetes disease management interventions were identified. Accepted
publications were abstracted into an evidence table and included in the data
interpretation. RESULTS: In total, 37 publications met the inclusion criteria and
were included in the analysis. Nine distinct categories of diabetes management
interventionswere identified and assessed: 1) counseling by healthcare provider; 2)
group treatment management sessions; 3) education/educational materials; 4)
telephone/telemedicine support; 5) web-based support; 6) self-management sup-
port; 7) pharmacist intervention; 8) physician education/support and 9) provision
of medication or testing supplies. CONCLUSIONS: All of the diabetes disease man-
agement interventions identified by this systematic review were associated with
significantly improved health outcomes, suggesting that patients will benefit from
any strategy undertaken. Combinations of multiple interventions demonstrated
the best clinical outcomes. It was not possible, however, to determine which inter-
ventions would be most effective, given a lack of direct comparisons and potential
reporting biases.
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OBJECTIVES: The expenditures for oral anti-diabetic medications have grown
markedly over the last decade. This study examined the patterns of use and ex-
penditures of individual anti-diabetic drug classes between 1999 and 2009.
METHODS:Weobtained a 0.2% sample ofmonthly ambulatory claims fromTaiwan
National Health Insurance. We assessed volume (DDD/patient/quarter) and gov-
ernment reimbursed costs (costs/patient/quarter) for each antidiabetic drug group
over 11 years. RESULTS: Between 1999 and 2009, the number of diabetic prescrip-
tion (patient) increased steadily at an average rate of 12.2% per year. Utilization of
oral anti-diabetic drugs increased from 246.05 ddd/patient in 1999_Q1 to 334.28
ddd/patient in 2003_Q2, then began to decrease; this change was due to a marked
reduction of sulfonylureas (from 235.88 ddd/patient [79.16% of total DDDs] in
2003_Q2 to 140.37 ddd/patient [58.15% of total DDDs] in 2009_Q4). Use of biguanides
was relatively stable over the study period (average rate 61.56 ddd/patient; 23% of
the market; 646.53 NT$/patient). In 2004_Q2, there was clear shift in use from an
older gliclazide (account for 48.40% of sulfonylureas in 2004_Q2) to a newer agent,
glimepiride (24.12%). Rosiglitazone’s use (70.37% of thiazolidinediones) dropped
rapidly from 2004_Q2 due to the safety concern of cardiovascular risk. The total
costs of anti-diabetic medications increased from NT$1931.91/patient in 1999_Q1
to NT$3446.95/patient in 2004_Q2, then began to subsequently a downward trend
(NT$2380.50/patient in 2009_Q4), primarily due to a substantial reduction in thia-
zolidinediones (1,100.57 NT$/patient [29.92% of total costs] and 2004_Q2 to 569.63
NT$/patient [23.92% of total costs] in 2009_Q4). CONCLUSIONS: Sulfonylureas and
biguanides, generally recommended as first-line therapies, dominated the Taiwan
market for diabetic management (86%100% of total DDDs) over the last decade.
Uptake of newer, more expensive agents, namely thiazolidinediones and alpha-
glucosidase inhibitors, was small. Our results suggest the utilization pattern of oral
anti-diabetic medications in Taiwan is overall consistent with clinical guidelines.
PDB93
IMPACTS OF DRUG REIMBURSEMENT RATE REDUCTIONS ON USE OF ORAL
ANTIDIABETIC MEDICATIONS IN TAIWAN: AN INTERRUPTED TIME SERIES
STUDY
Hsu CSJ1, Lu CY1, Wagner A2, Chan KWA3, Lai MS4, Ross-degnan D2
1Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA, 2Harvard
Medical School, Boston, MA, USA, 3Harvard School of Public Health, Boston, MA, USA, 4National
Taiwan University, Taipei, Taiwan
OBJECTIVES: Rapid growth of pharmaceutical costs is a major health care issue in
all countries. Taiwan has implemented several drug reimbursement rate reduc-
tions since April 2000. This research focuses on changes in use of oral antidiabetic
medications following the November 2006 price regulation. METHODS: We ob-
tained a 0.2% sample of monthly ambulatory claims from Taiwan National Health
Insurance for January 2006 through August 2007. We examined 179 products in
seven ATC categories of oral antidiabetics reimbursed, classified as either affected
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